Your browser doesn't support javascript.
loading
Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitochondrial pyruvate availability.
Jung, Kyung-Ho; Lee, Jin Hee; Park, Jin-Won; Moon, Seung-Hwan; Cho, Young Seok; Lee, Kyung-Han.
Afiliación
  • Jung KH; Department of Nuclear Medicine, Samsung Medical Center, Seoul 135-710, Republic of Korea.
  • Lee JH; Department of Nuclear Medicine, Samsung Medical Center, Seoul 135-710, Republic of Korea.
  • Park JW; Department of Nuclear Medicine, Samsung Medical Center, Seoul 135-710, Republic of Korea.
  • Moon SH; Department of Nuclear Medicine, Samsung Medical Center, Seoul 135-710, Republic of Korea.
  • Cho YS; Department of Nuclear Medicine, Samsung Medical Center, Seoul 135-710, Republic of Korea.
  • Lee KH; Department of Nuclear Medicine, Samsung Medical Center, Seoul 135-710, Republic of Korea.
Oncol Rep ; 43(2): 711-717, 2020 02.
Article en En | MEDLINE | ID: mdl-31894283

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Ácido Pirúvico / Troglitazona / Mitocondrias / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Ácido Pirúvico / Troglitazona / Mitocondrias / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article